Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Distribution Solutions Group
DSGR
$1.6B
| $6.14M | ﹤0.01% |
229,598
+16,790
| +8% | +$463K |
|
2777
Tonix Pharmaceuticals
TNXP
$170M
| $6.13M | ﹤0.01% |
9
+4
| +80% | +$2.94M |
|
|
DRRX
2778
DELISTED
DURECT Corp
DRRX
| $6.11M | ﹤0.01% |
374,724
+20,806
| +6% | +$363K |
|
2779
Hims & Hers Health
HIMS
$7.13B
| $6.11M | ﹤0.01% |
560,695
+17,020
| +3% | +$202K |
|
|
CMBM
2780
DELISTED
Cambium Networks
CMBM
| $6.09M | ﹤0.01% |
125,931
+7,397
| +6% | +$395K |
|
2781
ANI Pharmaceuticals
ANIP
$1.82B
| $6.08M | ﹤0.01% |
173,422
+13,408
| +8% | +$456K |
|
2782
Zevra Therapeutics
ZVRA
$594M
| $6.06M | ﹤0.01% |
472,854
+294,874
| +166% | +$3.17M |
|
|
VEI
2783
DELISTED
Vine Energy Inc.
VEI
| $6.05M | ﹤0.01% |
+388,401
| New | +$5.34M |
|
2784
Neuronetics
STIM
$150M
| $6.05M | ﹤0.01% |
377,600
+212,430
| +129% | +$2.94M |
|
|
APLT
2785
DELISTED
Applied Therapeutics
APLT
| $6.04M | ﹤0.01% |
290,920
+34,953
| +14% | +$662K |
|
2786
Flexsteel Industries
FLXS
$317M
| $6.04M | ﹤0.01% |
149,540
+50,112
| +50% | +$2.19M |
|
2787
Tilly's
TLYS
$121M
| $6.03M | ﹤0.01% |
377,208
+8,108
| +2% | +$109K |
|
|
WSR
2788
DELISTED
Whitestone REIT
WSR
| $6.02M | ﹤0.01% |
730,054
-128,921
| -15% | -$1.16M |
|
2789
Lufax Holding
LU
$1.31B
| $6.02M | ﹤0.01% |
134,459
+10,860
| +9% | +$547K |
|
|
HYRE
2790
DELISTED
HyreCar Inc. Common Stock
HYRE
| $6.02M | ﹤0.01% |
287,766
+140,379
| +95% | +$2.16M |
|
|
CSSE
2791
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $6.02M | ﹤0.01% |
145,346
+103,946
| +251% | +$3.65M |
|
2792
Cue Biopharma
CUE
$113M
| $6.01M | ﹤0.01% |
17,211
+1,009
| +6% | +$391K |
|
2793
Forte Biosciences
FBRX
$1.57B
| $6M | ﹤0.01% |
7,138
+3,636
| +104% | +$3.28M |
|
2794
Cullinan Oncology
CGEM
$999M
| $6M | ﹤0.01% |
232,922
+12,655
| +6% | +$389K |
|
2795
Franklin Covey
FC
$244M
| $5.99M | ﹤0.01% |
185,154
+4,705
| +3% | +$145K |
|
|
XONE
2796
DELISTED
The ExOne Company
XONE
| $5.97M | ﹤0.01% |
275,907
+34,043
| +14% | +$775K |
|
|
BDSI
2797
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $5.97M | ﹤0.01% |
1,666,947
+43,689
| +3% | +$154K |
|
2798
NVE Corp
NVEC
$595M
| $5.96M | ﹤0.01% |
80,546
+741
| +0.9% | +$52.8K |
|
2799
Olema Pharmaceuticals
OLMA
$985M
| $5.95M | ﹤0.01% |
212,522
-1,701
| -0.8% | -$48.4K |
|
2800
Root
ROOT
$903M
| $5.94M | ﹤0.01% |
30,488
+16,240
| +114% | +$3.07M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.